Stock PHIO PHIO PHARMACEUTICALS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Phio Pharmaceuticals Corp.

Equities

PHIO

US71880W5013

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
5.245 USD +0.33% Intraday chart for Phio Pharmaceuticals Corp. -15.78% -23.32%
Jul. 02 Phio Pharmaceuticals Board Approves 1-For-9 Reverse Stock Split MT
May. 28 Phio Pharmaceuticals Corp. Announces Positive Recommendation from Safety Monitoring Committee of Phase 1b Clinical Study of Phio's Lead Compound PH-762 CI

Evolution of the average Target Price on Phio Pharmaceuticals Corp.

Price target over the last 5 years

History of analyst recommendation changes

57a99d754809a488.79fILKjqPNnsqKjTQ8A4b8n5H2JA0FFeXoidHuYjdy4.tu6FZtnHRIOr3-aDMZIICPqwMggWpwI8br7JUqBLQH6Ng49u_YVIqrny4Q~4ed7f5b5c3d5f4a65be5fe9e8b34c9a9

Analyst Recommendations on Phio Pharmaceuticals Corp.

HC Wainwright Adjusts Price Target on Phio Pharmaceuticals to $4 From $6, Keeps Buy Rating MT
PHIO PHARMACEUTICALS : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target to $6 From $4, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.245 USD
Average target price
36 USD
Spread / Average Target
+586.41%
High Price Target
36 USD
Spread / Highest target
+586.41%
Low Price Target
36 USD
Spread / Lowest Target
+586.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Phio Pharmaceuticals Corp.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHIO Stock
  4. Consensus Phio Pharmaceuticals Corp.